Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001193125-26-377309

Chief Medical Officer sold 7,068 shares at an average $60.25 ($425,829)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

KENNEY CHRISTOPHER JOHN · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-28 Sale : show line 1 in the form 10b5-1 −6,368 $60.17 $383,145 702 D
2026-08-28 Sale : show line 2 in the form 10b5-1 −700 $60.98 $42,684 2 D
Open-market sales · 7,068 sh · avg $60.25 · $425,829
Loading xslF345X06/ownership.xml…